Baku 11° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
17:22
Azerbaijani PM, Montenegro's foreign minister mull expanding bilateral cooperation
Foreign policy17:11
Central Asia–Center gas pipeline disrupted in Russia's Volgograd region
Other countries17:10
Azerbaijan raises cement exports in January–November
Business16:52
Erdogan: Türkiye's defense exports rise 30% since start of year
Other countries16:36
Azerbaijan boosts direct investment in Türkiye in January–September
Finance16:24
Jordanian Air Force strikes Islamic State targets in Syria
Other countries16:16
Ukraine and Portugal agree on joint production of maritime drones — UPDATE
Other countries16:03
Azerbaijan boosts direct investment in Russia in January–September
Finance15:45
Photo